88IV - Public company info - Biocytogen Pharmaceuticals (Beijing) Co. Ltd.- H Shares

Input the stock code or the company name

Biocytogen Pharmaceuticals (Beijing) Co. Ltd.- H Shares, 02315.HK - Cash Flow	2021-12	2020-12
Net Cash Flow from Operating Activities	-365,778	-225,313
Net Cash Flow from Return on Investments & Servicing of Finance	-7,663	-4,007
Interest Received	0	0
Interest Paid	-7,663	-4,007
Dividend Received	0	0
Dividend Paid	0	0
Others	0	0
Taxes (Paid) / Refunded	0	0
Net Cash Flow from Investing Activities	-84,131	-188,180
Additions to Fixed Assets	-198,668	-296,420
Disposal of Fixed Assets	4,757	45
Increase in Investments	-540,000	-1,285,000
Decrease in Investments	649,780	1,393,195
Net Cash Flow with Related Parties	311,040	948,360
Others	-311,040	-948,360
Net Cash Flow before Financing Activities	-457,572	-417,500
Net Cash Flow from Financing Activities	253,908	872,449
New Loans	0	0
Loans Repayment	-14,978	-20,632
Fixed Income/Debt Instruments	0	0
Repayment of Fixed Income/Debt Instruments	0	0
Equity Financing	0	0
Net Cash Flow with Related Parties	311,040	948,360
Others	-42,154	-55,279
Increase(Decrease) in Cash & Cash Equivalents	-203,664	454,949
Cash & Cash Equivalents at Beginning of Year	697,294	246,384
Net Cash Flow due to Change in Exchange Rate/Others	-380	-4,039
Cash & Cash Equivalents at End of Year	493,250	697,294
Currency	Renminbi	Renminbi
Unit
Auditor's Opinion	0	0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Public company info - Biocytogen Pharmaceuticals (Beijing) Co. Ltd.- H Shares , 02315.HK